Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Since 2004, public interest in infrared saunas has grown, with online searches related to infrared saunas increasing 500% since 2004. The interest and curiosity have prompted more (though still limited) research. Much of this research relates to traditional sauna bathing. For most healthy adults, moderate use of an infrared sauna (coupled with adequate hydration) is […]

The post Are There Any Side Effects Of Using An Infrared Sauna? What The Research Shows appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

The truth is right out of the gate: Invisalign is effective for many adults but it’s not easy. The aligners should be in your mouth for 20-22 hours each day, only for water, and results will depend on how often the aligners are worn. Once you can establish that habit, and most busy adults can, […]

The post Invisalign for Busy Adults: What to Know Before You Start appeared first on Medical News Bulletin.

A group of 52 attorneys general announced a proposed settlement with Meta over allegations that it misled the public about features in Instagram and Facebook that may be harmful to the mental health of children and adolescents.
“Today, we have secured a settlement with Meta that will make social media less dangerous for our kids and make a world of difference for children and their families,” California Attorney General Rob Bonta said in a press release.
The attorneys general alleged that Instagram and Facebook were designed to drive compulsive use among children and adolescents, harming them

DENVER — Two studies presented at the Association for Research in Vision and Ophthalmology meeting explored the benefits of ATSN-101 for Leber congenital amaurosis and ATSN-201 for X-linked retinoschisis.
In July, Atsena Therapeutics received orphan drug designation for the two gene therapy candidates from the European Medicines Agency, according to a press release.
“Receiving orphan designation from the EMA for both ATSN-101 and ATSN-201 underscores that these programs address significant unmet needs for patients who currently have no treatment options,” Atsena CEO Patrick Ritschel said in the

Hormone replacement therapy, or HRT, may lower the risk for dementia among postmenopausal women, new data in Alzheimer’s & Dementia show.
The findings — although not showing causality — align with recently published data, which showed that women who used estrogen-only menopausal hormonal therapy later in life had lower risks for clinical dementia diagnoses and functional and memory decline.
“Dementia affects millions of people worldwide, with women making up almost two-thirds of Alzheimer’s disease cases, the main form of dementia,” Anne-Marie Minihane, PhD, a professor of nutrigenetics at

Legato Frames, a set of eyeglass frames equipped with speakers in the arms for hearing assistance, will be available this fall, according to the manufacturer.
“Legato Frames were designed to overcome the stigma and cost barriers of hearing aids,” the company told Healio. “They were designed for everyday use and are particularly helpful in situations where hearing can be difficult, including noisy environments such as restaurants.”
The frames are intended for people with mild to moderate hearing loss and are classified by the FDA as an over-the-counter hearing aid,

Rates of substance use fell among adolescents and young adults across most substances between 2021 and 2025, even as marijuana use increased among adults aged 26 years and older, according to the 2025 National Survey on Drug Use and Health.
Substance use began declining among children aged 12 to 17 years prior to the COVID-19 pandemic, and those trends seem to be continuing among young adults aged 18 to 25 years in the new data, said Chris Jones, PharmD, DrPH, MPH, director of the Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration (SAMHSA).

The FDA has approved RHA Redensity Eye, a specialized hyaluronic acid dermal filler, for the correction of moderate to severe volume loss and hollowing under the eyes, Revance and Teoxane announced in a press release.
The formula, which is part of the Teoxane RHA Collection, is available for adults aged 22 years or older.
“Treating the periorbital area is not straightforward,” Valérie Taupin, CEO and founder of Teoxane, said in the release. “The properties of RHA Redensity Eye provide an answer for it. Its spreadability, stretch and soft profile are exactly what this anatomy requires.”
Created

GSK and Merck, which manufacture MMR vaccines in the United States, told Healio there is no scientific evidence that separating the vaccines into three components will improve safety.
Moreover, a Merck spokesperson said separating the vaccine into three separate vaccines against measles, mumps and rubella could take up to a decade.
In an executive order signed earlier this month, President Donald J. Trump said the MMR shot should be split up and administered as three separate vaccines.
But experts have said there is no scientific evidence to support the change, which could reduce vaccination

Results of a registry analysis on the real-world use of aflibercept 8 mg in treatment-naive and previously treated eyes with diabetic macular edema were presented at the American Society of Retina Specialists annual meeting.
“This is a registry study [on Eylea HD (aflibercept 8 mg, Regeneron)], so we don’t have individual patient-level data, and unfortunately, at this time, we don’t have the ability to look at the OCTs, but this, to me, is quite helpful in my day-to-day decision-making” Sunir J. Garg, MD, FACS, FASRS, chief of the retina service at Wills Eye Hospital and professor of